Susquehanna International »

Aktis Oncology shares owned by Susquehanna International

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Susquehanna International

Quarter filed Position value Share count Share price at filing
2026-06-30 $278k 8.6k 32.23

More positions owned by Susquehanna International

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)

View all positions for Susquehanna International

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology